Special webinar featuring WellDyneRx clinical leaders presenting our 2017 Drug Trend Report. This 60 minutes presentation provides insights on how our 2017 Drug Trend Report underscores our goal to drive improved patient outcomes and lower costs.
Highlights of Webinar:
• WellDyneRx clients experienced an overall 1.2% increase in per member per year (PMPY) costs from 2016 to 2017.
• Specialty represented 35.7% of overall drug spend in 2017
• WellDyneRx had lower overall trend than the largest national PBMs
• WellDyneRx experienced a negative specialty unit cost trend while others showed a 3% increase or more
Please complete the form below for full access to this webinar.
Nick Page, PharmD, Chief Pharmacy Officer, WellDyneRx
Patty Taddei-Allen, PharmD, MBA, Director, Outcomes Research, WellDyneRx
Denise Cabrera, Senior Vice President, Client Services, WellDyneRx